OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma
Yaxiao Lu, Yang Li, Jingwei Yu, et al.
Clinical Immunology (2023) Vol. 251, pp. 109637-109637
Closed Access | Times Cited: 6
Yaxiao Lu, Yang Li, Jingwei Yu, et al.
Clinical Immunology (2023) Vol. 251, pp. 109637-109637
Closed Access | Times Cited: 6
Showing 6 citing articles:
Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway
Qiqi Zhu, Yiming Yang, Kexin Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Qiqi Zhu, Yiming Yang, Kexin Chen, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands
Zhuohong Yan, Teng Ma, Xiaojue Wang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28126-e28126
Open Access | Times Cited: 4
Zhuohong Yan, Teng Ma, Xiaojue Wang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28126-e28126
Open Access | Times Cited: 4
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
Sylvie Rusakiewicz, Svitlana Tyekucheva, S. Tissot-Renaud, et al.
European Journal of Cancer (2024) Vol. 200, pp. 113535-113535
Closed Access | Times Cited: 1
Sylvie Rusakiewicz, Svitlana Tyekucheva, S. Tissot-Renaud, et al.
European Journal of Cancer (2024) Vol. 200, pp. 113535-113535
Closed Access | Times Cited: 1
TIGIT: Will it be the next star therapeutic target like PD-1 in hematological malignancies?
Yang Liu, Wenhui Liu, Tao Wu
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104495-104495
Closed Access
Yang Liu, Wenhui Liu, Tao Wu
Critical Reviews in Oncology/Hematology (2024) Vol. 204, pp. 104495-104495
Closed Access
Preclinical pharmacology characterization of HX009, a novel PD1 x CD47 Bi-specific antibody
Hang Ke, Tao Yang, Faming Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Hang Ke, Tao Yang, Faming Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Prognostic analysis of prostaglandin D2 synthase in diffuse large B-cell lymphoma
Jiesong Wang, Yun Xu, Wei Yu, et al.
Holistic Integrative Oncology (2023) Vol. 2, Iss. 1
Open Access
Jiesong Wang, Yun Xu, Wei Yu, et al.
Holistic Integrative Oncology (2023) Vol. 2, Iss. 1
Open Access
